Chemist Gets Fired After Calling Breast Implant Unsafe

OTTAWA—Research chemist J.J.B. Pierre Blais joined the health protection branch of Canada’s Department of National Health and Welfare in 1976 in the midst of a productive career in the federal science bureaucracy. He had spent seven years at the National Research Council, and looked forward to many more satisfying years with his new agency. For a while it was just that. An expert in the biocompatibility of implant materials, Blais has worked on projects that have led to amendme

Written byDavid Spurgeon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

OTTAWA—Research chemist J.J.B. Pierre Blais joined the health protection branch of Canada’s Department of National Health and Welfare in 1976 in the midst of a productive career in the federal science bureaucracy. He had spent seven years at the National Research Council, and looked forward to many more satisfying years with his new agency.

For a while it was just that. An expert in the biocompatibility of implant materials, Blais has worked on projects that have led to amendments in Canada’s Medical Devices Regulations and served as section head within the department. “He’s a brilliant scientist who is always searching for the truth,” says one of his superiors, Agit Das Gupta. Blais also built a reputation as an innovative and productive investigator, with some 180 published articles, book chapters, patents, and monographs.

But six weeks ago Blais, at the age of 49, was fired from his job. And he blames ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies